University of Minnesota. Driven to Discover.
In another new development, the NIH today announced the start of the first human trial of a live attenuated vaccine against Zika.
Also, the species might be resistant to cold temperatures.
A separate study found Zika virus in the saliva of 5 different mosquito species in Mexico.
Also, reseachers identify a Zika antibody that might open up new therapy and vaccine possibilities.
The cost study looked at different attack-rate ranges, putting the upper-end estimate at as much as $2 billion.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.